ResMed trades at $254.11 per share and has stayed right on track with the overall market, gaining 8.9% over the last six ...

Shares of ResMed Inc. RMD shed 1.42% to $254.40 Friday, on what proved to be an all-around rough trading session for the ...

The first blue chip ASX 200 share that could be a buy is REA Group. It is the dominant player in Australia's online real ...

This ASX 200 share is quietly becoming a global leader in diagnostic imaging software. Its flagship product, Visage 7, ...

Australia’s sharemarket is about to notch a third straight year of falling profits and 2026 doesn’t look much better. But ...

If you spend any time in post-acute care today, whether in a skilled nursing facility, an assisted living community, or a ...

Millions of Indians are struggling to sleep well, whether due to stress, anxiety or not being able to turn off their phones.

It isn't as hard as you might think to invest like the Oracle of Omaha. The post 5 easy steps to invest like Warren Buffett ...

The digital therapeutics (DTx) market is experiencing significant growth with a projected CAGR of 25-27% over the next few ...

Australia’s sharemarket fell during Wednesday’s trading as US President Donald Trump’s tariff policy hits two key market ...